Your session is about to expire
← Back to Search
Kindolor Cohort 1 for Chronic Pain
Study Summary
This trial aims to test Kindolor in healthy adults to find out the safe dose and how the body processes it. Participants will receive Kindolor or a placebo and undergo medical tests to compare the effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has Kindolor Cohort 1 received approval from the FDA?
"Our research team at Power has appraised the safety of Kindolor Cohort 1 as a level 1 on our scale from 1 to 3. This assessment is due to the trial being in Phase 1, indicating sparse evidence backing its safety and effectiveness."
Are individuals older than 80 years being enrolled in this study?
"The enrollment criteria for this research study require participants to fall within the age range of 18-55 years. Notably, there are a total of 37 investigations tailored for individuals under 18 and 352 studies aimed at those over 65."
Am I eligible to enroll in this clinical trial?
"Participants meeting the eligibility criteria must exhibit chronic pain and fall between 18 to 55 years of age. The trial aims to enroll a total of 32 individuals."
Is the enrollment for this investigation presently open?
"As per clinicaltrials.gov data, this investigation is no longer seeking subjects. Originally uploaded on April 1st, 2024 and last revised on January 29th, 2024. Despite its closure to further participants, there are currently 396 alternative trials open for enrollment."
Share this study with friends
Copy Link
Messenger